Who is sponsoring NCT02237781?

NCT02237781 is sponsored by University of Athens.

What condition does NCT02237781 study?

NCT02237781 studies Female Infertility.

What is the status of NCT02237781?

NCT02237781 is currently UNKNOWN.

Last reviewed 2014-09-10 · How we verify

Prospective Randomized Trial on the Level of Anti-Mullerian Hormone (AMH) in Women Undergoing Controlled Ovarian Stimulation for IVFwith Gonadotropins.

NCT02237781 Phase 2/Phase 3 UNKNOWN

Anti-Mullerian Hormone (AMH) is produced only in small ovarian follicles with quite stable levels during the cycle. There is not yet sufficient data to inform couples undergoing IVF about the effect of ovarian stimulation on the levels of AMH due to the increasing size of follicles and chances of success of the method.

Details

Lead sponsor	University of Athens
Phase	Phase 2/Phase 3
Status	UNKNOWN
Enrolment	50
Start date	2014-10
Completion	2015-12

Conditions

Female Infertility

Interventions

Gonadotropins

Primary outcomes

Level of AMH — 6 months
Anti-Mullerian Hormone (AMH) will be measured prior to the initiation of treatment and during ovarian stimulation.